Eccogene Inc.
2Patents
2Active
2Granted
52Portfolio score
Filing activity: Jul 20, 2021 → Aug 11, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12037339B2 | Substituted imidazoles as GLP-1 receptor agonists | Chemistry; Metallurgy | 0 | Active |
| US12291518B2 | Thyroid hormone receptor agonists and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.